Please login to the form below

Not currently logged in
Email:
Password:

UCB CEO elected to the Ministerial Industry Strategy Group

Jean-Christophe Tellier assumed the role of CEO on January 1
Jean-Christophe Tellier

UCB's new CEO Jean-Christophe Tellier has been elected to join the Ministerial Industry Strategy Group (MISG).

Tellier was elected by member of the European Medicines Group (EMG) and will act as group representative for the European pharma companies.

Commenting on the election, Tellier said: “The UK life sciences industry is one of the most successful at a global level and it is an important contributor to the country's economic prosperity.

“Therefore, I am pleased to be sharing some of UCB's experience as an inward R&D inward investor with the MISG, in an effort to shape a positive climate that incentivises innovation for the improvement of patient care.”

Tellier joined UCB in 2011 as an executive VP after serving as president of Ipsen, North America, and CEO of Novartis pharma France. He has 25 years of experience in the industry, aided by a medical background as a rheumatologist.

Tellier was named as UCB's next CEO early last year, but did not assume the role until January 1 of this year.

25th February 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics